Altered bleomycin-induced lung fibrosis in osteopontin-deficient mice.
D000818:Animals; D000903:Antibiotics, Antineoplastic; D001761:Bleomycin; D024042:Collagen Type I / Q000235:genetics; D005260:Female; D015870:Gene Expression; D008297:Male; D020778:Matrix Metalloproteinase 2 / Q000235:genetics; D051379:Mice; D008817:Mice, Mutant Strains; D053495:Osteopontin; D011014:Pneumonia / Q000139:chemically induced / Q000473:pathology / Q000503:physiopathology*; D011658:Pulmonary Fibrosis / Q000139:chemically induced / Q000473:pathology / Q000503:physiopathology*; D012795:Sialoglycoproteins / Q000235:genetics*; D015398:Signal Transduction / Q000502:physiology; D016212:Transforming Growth Factor beta / Q000235:genetics; D053773:Transforming Growth Factor beta1
D000903:Antibiotics, Antineoplastic; D024042:Collagen Type I; C506895:SPP1 protein, human; D012795:Sialoglycoproteins; C506896:Spp1 protein, mouse; C508960:TGFB1 protein, human; C508961:Tgfb1 protein, mouse; D016212:Transforming Growth Factor beta; D053773:Transforming Growth Factor beta1; D053495:Osteopontin; D001761:Bleomycin; D020778:Matrix Metalloproteinase 2